SCHEMBL19397465

SCHEMBL19397465

c1ccc(-c2ccc(-c3cc(-c4cccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)cc5)c4)nc(-c4cccs4)n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 2/20 0.50
▸ ESR1 P03372 1/20 0.46
▸ KDM4E B2RXH2 10/20 0.44
▸ ALDH1A1 P00352 8/20 0.44
▸ HPGD P15428 8/20 0.44
▸ POLB P06746 2/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ PLA2G1B P04054 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ATG4B Q9Y4P1 1/20 0.41
▸ GRIA1 P42261 1/20 0.41
▸ CACNG8 Q8WXS5 1/20 0.41
▸ CACNG2 Q9Y698 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19397578 0.95 ESR2 (0.51) ESR2ESR1KDM4EALDH1A1HPGD
SCHEMBL21158507 0.87 ESR1 (0.54) ESR2ESR1KDM4EALDH1A1HPGD
SCHEMBL19369873 0.87 ESR1 (0.54) ESR2ESR1KDM4EALDH1A1HPGD
SCHEMBL19369870 0.85 ESR1 (0.56) ESR2ESR1KDM4EALDH1A1HPGD
SCHEMBL22310189 0.85 ESR1 (0.56) ESR2ESR1KDM4EALDH1A1HPGD
SCHEMBL21158506 0.85 ESR1 (0.56) ESR2ESR1KDM4EALDH1A1HPGD
SCHEMBL21158000 0.85 ESR1 (0.56) ESR2ESR1KDM4EALDH1A1HPGD
SCHEMBL21158039 0.85 ESR1 (0.56) ESR2ESR1KDM4EALDH1A1HPGD
SCHEMBL19397461 0.84 KDM4E (0.41) KDM4EALDH1A1HPGDPOLBSMN1; SMN2
SCHEMBL19397445 0.84 KMT2A (0.49) ESR2ESR1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 — — US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 — — US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM ESR2 510/4885ESR1 84/4885KDM4E 2356/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 ESR2 511/4885ESR1 41/4885KDM4E 2750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback